Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ARUNIMA MISRA and SALIM VIRANI.
ARUNIMA MISRA
Connection Strength
2.067
SALIM VIRANI
  1. Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270.
    View in: PubMed
    Score: 0.222
  2. Association Between Social Vulnerability Index and Cardiovascular Disease: A?Behavioral Risk Factor Surveillance System Study. J Am Heart Assoc. 2022 08 02; 11(15):e024414.
    View in: PubMed
    Score: 0.199
  3. SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? Curr Atheroscler Rep. 2022 08; 24(8):627-634.
    View in: PubMed
    Score: 0.197
  4. Use of Preventive Cardiovascular Health Care Among Asian American Individuals: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Aug; 48(8):101241.
    View in: PubMed
    Score: 0.196
  5. Mental Health and Access to Medical Care in Patients with Chronic Cardiovascular Conditions: An Analysis of the Behavior Risk Factor Surveillance System. Kans J Med. 2022; 15:17-21.
    View in: PubMed
    Score: 0.192
  6. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2021 07 01; 6(7):782-790.
    View in: PubMed
    Score: 0.185
  7. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. Am J Prev Cardiol. 2021 Mar; 5:100150.
    View in: PubMed
    Score: 0.180
  8. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Curr Atheroscler Rep. 2020 07 16; 22(9):44.
    View in: PubMed
    Score: 0.173
  9. Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors. Am J Cardiovasc Drugs. 2025 Jul 12.
    View in: PubMed
    Score: 0.061
  10. Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
    View in: PubMed
    Score: 0.059
  11. Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
    View in: PubMed
    Score: 0.059
  12. The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.
    View in: PubMed
    Score: 0.058
  13. Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112.
    View in: PubMed
    Score: 0.056
  14. County-Level Cardiologist Density and Mortality in the United States. J Am Heart Assoc. 2023 12 05; 12(23):e031686.
    View in: PubMed
    Score: 0.055
  15. Association Between Cardiologist Density and Mortality in Urban and Rural Counties in the United States. Am J Cardiol. 2024 01 01; 210:279-282.
    View in: PubMed
    Score: 0.054
  16. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol. 2019 07 15; 124(2):296-302.
    View in: PubMed
    Score: 0.040
  17. Postprandial effects on arterial stiffness parameters in healthy young adults. Vasc Med. 2015 Dec; 20(6):501-8.
    View in: PubMed
    Score: 0.030
  18. Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr. 2013 Aug; 26(8):901-909.e1.
    View in: PubMed
    Score: 0.026
  19. Segmental analysis of carotid arterial strain using speckle-tracking. J Am Soc Echocardiogr. 2011 Nov; 24(11):1276-1284.e5.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.